<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Bullous <z:hpo ids='HP_0000999'>pyoderma</z:hpo> gangrenosum begins as a <z:mp ids='MP_0008854'>bulla</z:mp>, nodule or nonulcerated erythematous plaque that <z:hpo ids='HP_0008066'>blisters</z:hpo> or ulcerates to form a superficial <z:mpath ids='MPATH_579'>ulcer</z:mpath> surrounded by a hemorrhagic, bullous border, which is surrounded by a blue-gray halo </plain></SENT>
<SENT sid="1" pm="."><plain>Bullous <z:hpo ids='HP_0000999'>pyoderma</z:hpo> gangrenosum is most commonly associated with <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e>, specifically, <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>We report a patient whose initial presentation with bullous <z:hpo ids='HP_0000999'>pyoderma</z:hpo> gangrenosum prompted the appropriate diagnostic evaluation and confirmation of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, which was ultimately fatal </plain></SENT>
<SENT sid="3" pm="."><plain>We emphasize that a thorough hematologic investigation, including bone marrow biopsy, should be performed in <z:hpo ids='HP_0000001'>all</z:hpo> patients who present with lesions clinically suggestive of bullous <z:hpo ids='HP_0000999'>pyoderma</z:hpo> gangrenosum because the skin lesion may be the only indicator of the underlying <z:e sem="disease" ids="C1521860" disease_type="Disease or Syndrome" abbrv="">hematologic disorder</z:e> </plain></SENT>
</text></document>